ABG
CERE
Ally Bridge Group’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-170,000
| Closed | -$4.5M | – | 47 |
|
|
2022
Q2 | $4.5M | Hold |
170,000
| – | – | 4.1% | 10 |
|
|
2022
Q1 | $5.95M | Buy |
+170,000
| New | +$5.95M | 4.41% | 9 |
|
|
2021
Q3 | – | Sell |
-675,670
| Closed | -$17.3M | – | 35 |
|
|
2021
Q2 | $17.3M | Sell |
675,670
-1,052,920
| -61% | -$27M | 4.3% | 6 |
|
|
2021
Q1 | $23.7M | Sell |
1,728,590
-38,850
| -2% | -$533K | 4.55% | 3 |
|
|
2020
Q4 | $29.3M | Buy |
+1,767,440
| New | +$29.3M | 5.02% | 3 |
|